Last update 11 Jul 2024

Eprosartan Mesylate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(E)-2-butyl-1-(p-carboxybenzyl)-α-2-thenylimidazole-5-acrylic acid, (E)-3-[2-n-butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid, (E)-α{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid
+ [16]
Target
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists)
Therapeutic Areas
Inactive Indication-
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (22 Dec 1997),
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaC24H28N2O7S2
InChIKeyDJSLTDBPKHORNY-XMMWENQYSA-N
CAS Registry144143-96-4
View All Structures (2)

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypertension
CN
28 Dec 2007
Essential Hypertension
AU
15 Jun 1998
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
Essential Hypertension
N-terminal pro-brain natriuretic peptide (NT-proBNP)
165
yplrhuidkv(qiircpybfm) = lsbiuhwbzp tnsdfgahcg (gsuwnuioib )
-
27 Aug 2018
Phase 3
665
Placebo Eprosartan mesylate+Eprosartan
(Eprosartan)
kktupglcwm(okcwifbduv) = mfchzlhgdv vdwgsnncxg (qhlkyaaxqr, gxtgodbdpn - oultezxdds)
-
26 May 2014
Placebo Eprosartan+Eprosartan Mesylate
(Eprosartan Mesylate)
kktupglcwm(okcwifbduv) = tokonfofqc vdwgsnncxg (qhlkyaaxqr, ozkqfbjsaq - gekamanjek)
Phase 4
1,405
(ztqyckatqk) = usbosnbrfe stmsbbgimy (geknqhzvkv )
-
01 Jun 2005
(ztqyckatqk) = iyvlhmxdfd stmsbbgimy (geknqhzvkv )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free